How Much Did ePatientFinder Raise?
Funding & Key Investors

ePatientFinder, currently operating under the brand Elligo Health Research, has successfully navigated multiple capital injection cycles to solidify its position in the clinical research infrastructure market. The firm has secured a cumulative total of $13.4M in financing, with the most recent strategic investment totaling $2.6M. This capital trajectory underscores the company's evolution from a niche patient recruitment platform into a comprehensive enterprise-level clinical trial management organization.

What is ePatientFinder?

ePatientFinder
Business ServicesResearch & Development

Elligo Health Research provides a sophisticated ecosystem for clinical trial management, integrating site support services with proprietary marketplace technology. By deploying the IntElligo Research Stack, the company bridges the gap between pharmaceutical sponsors and healthcare-first research sites. This infrastructure is designed to optimize patient recruitment, enhance data integrity, and accelerate study timelines across a global network of over 1,000 clinical trials. The company's market position is defined by its ability to transform traditional research workflows into digitized, efficient processes that prioritize patient access and therapeutic efficacy.

How much funding has ePatientFinder raised?

ePatientFinder has raised a total of $13.4M across 3 funding rounds:

2015

Series A

$2.6M

2016

Series B

$8.2M

2017

Debt

$2.6M

Series A (2015): $2.6M, investors not publicly disclosed

Series B (2016): $8.2M, investors not publicly disclosed

Debt (2017): $2.6M, investors not publicly disclosed

Key Investors in ePatientFinder

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for ePatientFinder?

With the infusion of recent capital, Elligo Health Research is positioned to scale its technological footprint and expand its network of research-ready sites. The strategic focus will likely center on deepening the integration of its research stack to further reduce the friction inherent in multi-site clinical trials. As the industry shifts toward decentralized and hybrid research models, Elligo is well-positioned to leverage its existing infrastructure to capture additional market share, potentially through enhanced data analytics capabilities and broader therapeutic area coverage. The company remains a critical player in the modernization of clinical research, aiming to streamline the path from drug development to patient care.

See full ePatientFinder company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingHuman Resources Management Systems (HRMS)
Accounting for Legal PracticesBusiness Services
Advertising NetworksBusiness Services
Business ServicesHuman Resources Management Systems (HRMS)

Frequently Asked Questions Regarding ePatientFinder Financial Insights

What are the most recent funding rounds that ePatientFinder has completed, and what were the funding rounds?
ePatientFinder has recently completed 3 funding rounds: Debt on Sep 12, 2017, Series B on Jun 8, 2016, Series A on Feb 9, 2015.
What is the total amount of funding ePatientFinder has raised to date?
ePatientFinder has raised a total of $13.4M in funding to date.
How many funding rounds has ePatientFinder completed?
ePatientFinder has completed 3 funding rounds.
How much funding did ePatientFinder raise in its most recent funding round?
ePatientFinder raised $2.6M in its most recent funding round.
Which was the largest funding round in ePatientFinder's history?
The largest funding round in ePatientFinder's history was $8.2M.
See more information about ePatientFinder